Non-canonical mTORC1 signaling at the lysosome

Gennaro Napolitano1, Chiara Di Malta1, Andrea Ballabio2

  • 1Telethon Institute of Genetics and Medicine (TIGEM), Via Campi Flegrei 34, 80078 Pozzuoli, Naples, Italy; Medical Genetics Unit, Department of Medical and Translational Science, Federico II University, Via Pansini 5, 80131 Naples, Italy.

Insights

The mechanistic target of rapamycin complex 1 (mTORC1) pathway has a newly discovered non-canonical signaling route. This pathway selectively controls microphthalmia/transcription factor E (MiT-TFE) activity, impacting cell metabolism.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • The mechanistic target of rapamycin complex 1 (mTORC1) is a central signaling hub integrating environmental cues to regulate cell growth and metabolism.
  • Significant progress has been made in understanding mTORC1 lysosomal recruitment and activation mechanisms.
  • Selective responses of mTORC1 to diverse signals have remained largely unclear.

Purpose of the Study:

  • To explore emerging evidence for a non-canonical mTORC1 signaling pathway.
  • To investigate how this pathway controls microphthalmia/transcription factor E (MiT-TFE) transcription factors.
  • To understand the physiological and disease relevance of this novel signaling route.

Main Methods:

  • Review of emerging scientific literature on mTORC1 signaling.
  • Analysis of mechanisms governing mTORC1 substrate recruitment.
  • Investigation of signaling pathways converging on the lysosomal surface.

Main Results:

  • Identification of a 'non-canonical' mTORC1 signaling pathway.
  • Demonstration that this pathway regulates the function of MiT-TFE transcription factors.
  • Evidence suggests this pathway responds to stimuli converging on the lysosomal surface.

Conclusions:

  • A novel non-canonical mTORC1 pathway selectively modulates MiT-TFE activity.
  • This pathway plays a role in regulating cell metabolism.
  • Understanding this pathway is crucial for comprehending physiological and disease conditions.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.0K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
7.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.3K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.2K